Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Bruton's Tyrosine Kinase in CLL. | Front Immunol | 2021 | 34248972 | PubTator, text mining | PubMed |
| A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions. | Front Immunol | 2021 | 34248965 | PubTator, text mining | PubMed |
| Interplay of Inflammatory, Antigen and Tissue-Derived Signals in the Development of Resident CD8 Memory T Cells. | Front Immunol | 2021 | 34234771 | PubTator, text mining | PubMed |
| New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011-2021) focussing on structure-activity relationship (SAR) and docking insights. | J Enzyme Inhib Med Chem | 2021 | 34233563 | PubTator, text mining | PubMed |
| Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis. | Gastroenterology | 2021 | 34224738 | PubTator, text mining | PubMed |
| Flavopiridol (Alvocidib), a Cyclin-dependent Kinases (CDKs) Inhibitor, Found Synergy Effects with Niclosamide in Cutaneous T-cell Lymphoma. | J Clin Haematol | 2021 | 34223559 | PubTator, text mining | PubMed |
| Steroid-refractory chronic graft-versus-host disease: treatment options and patient management. | Bone Marrow Transplant | 2021 | 34218265 | PubTator, text mining | PubMed |
| T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2021 | 34209724 | PubTator, text mining | PubMed |
| Making Potent CAR T Cells Using Genetic Engineering and Synergistic Agents. | Cancers (Basel) | 2021 | 34209505 | PubTator, text mining | PubMed |
| Management of T-Cell Lymphoma: In Quest of the Holy Grail. | Cancers (Basel) | 2021 | 34208034 | PubTator, text mining | PubMed |
| Molecular Genetics in Epstein-Barr Virus-Associated Malignancies. | Life (Basel) | 2021 | 34206255 | PubTator, text mining | PubMed |
| Two Sides of the Coin: Mast Cells as a Key Regulator of Allergy and Acute/Chronic Inflammation. | Cells | 2021 | 34203383 | PubTator, text mining | PubMed |
| Characterization of Rheumatoid Arthritis Risk-Associated SNPs and Identification of Novel Therapeutic Sites Using an In-Silico Approach. | Biology (Basel) | 2021 | 34199962 | PubTator, text mining | PubMed |
| Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments. | Cancers (Basel) | 2021 | 34198989 | PubTator, text mining | PubMed |
| A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? | Arthritis Rheumatol | 2021 | 34180156 | PubTator, text mining | PubMed |
| The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application. | Front Immunol | 2021 | 34177953 | PubTator, text mining | PubMed |
| Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review. | Front Immunol | 2021 | 34177941 | PubTator, text mining | PubMed |
| First-Line Therapy for Chronic Lymphocytic Leukemia: Bruton Tyrosine Kinase or BCL2 or Both? | Hematol Oncol Clin North Am | 2021 | 34174983 | PubTator, text mining | PubMed |
| T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH. | J Clin Immunol | 2021 | 34173902 | PubTator, text mining | PubMed |
| Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients. | Curr Med Sci | 2021 | 34170459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=46